Showing 1 - 9 results of 9 for search 'Hyung-don Kim', query time: 0.02s Refine Results
  1. 1
    Author response to comment on “Phase 2 study of neoadjuvant durvalumab plus docetaxel, oxaliplatin, and S-1 with surgery and adjuvant durvalumab plus S-1 for resectable locally advanced gastric cancer”

    Author response to comment on “Phase 2 study of neoadjuvant durvalumab plus docetaxel, oxaliplatin, and S-1 with surgery and adjuvant durvalumab plus S-1 for resectable locally adv... by Yoon-Koo Kang, Hyung-Don Kim, Min-Hee Ryu

    Published 2025-05-01
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    A Novel Mechanism of PPARγ Regulation of TGFβ1: Implication in Cancer Biology

    A Novel Mechanism of PPARγ Regulation of TGFβ1: Implication in Cancer Biology by Chang Ho Lee, Hyung Don Kim, Sang Mi Shin, Sang Geon Kim

    Published 2008-01-01
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Phase 2 study of neoadjuvant durvalumab plus docetaxel, oxaliplatin, and S-1 with surgery and adjuvant durvalumab plus S-1 for resectable locally advanced gastric cancer

    Phase 2 study of neoadjuvant durvalumab plus docetaxel, oxaliplatin, and S-1 with surgery and adjuvant durvalumab plus S-1 for resectable locally advanced gastric cancer by Yoon-Koo Kang, Jong Seok Lee, Hyung-Don Kim, Min-Hee Ryu, Young Soo Park, Hyungwoo Cho

    Published 2025-03-01
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    Roasted <i>Astragalus membranaceus</i> Inhibits Aβ25–35-Induced Oxidative Stress in Neuronal Cells by Activating the Nrf2/HO-1 and AKT/CREB/BDNF Pathways

    Roasted <i>Astragalus membranaceus</i> Inhibits Aβ25–35-Induced Oxidative Stress in Neuronal Cells by Activating the Nrf2/HO-1 and AKT/CREB/BDNF Pathways by Yun-Jeong Ji, Min Hye Kang, Sin Hee Han, Geum-Soog Kim, Hyung Don Kim, Gwi Yeong Jang

    Published 2024-10-01
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Lenvatinib versus sorafenib as second-line therapy following progression on atezolizumab–bevacizumab in patients with unresectable hepatocellular carcinoma: a multicenter retrospective study from Korea and Japan

    Lenvatinib versus sorafenib as second-line therapy following progression on atezolizumab–bevacizumab in patients with unresectable hepatocellular carcinoma: a multicenter retrospec... by Jaekyung Cheon, Shigeo Shimose, Hyung-Don Kim, Takashi Niizeki, Min-Hee Ryu, Tomotake Shirono, Baek-Yeol Ryoo, Hideki Iwamoto, Changhoon Yoo

    Published 2025-01-01
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Antitumor effects of immunotherapy combined with BRAF and MEK inhibitors in BRAF V600E metastatic colorectal cancer

    Antitumor effects of immunotherapy combined with BRAF and MEK inhibitors in BRAF V600E metastatic colorectal cancer by Eunyoung Tak, Hye-In An, Amy Sinyoung Lee, Kyuyoung Han, Jiwan Choi, Hyung-don Kim, Yong Sang Hong, Sun Young Kim, Eun Kyung Choi, Jeong Eun Kim, Tae Won Kim

    Published 2025-03-01
    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    Correction: Antitumor effects of immunotherapy combined with BRAF and MEK inhibitors in BRAF V600E metastatic colorectal cancer

    Correction: Antitumor effects of immunotherapy combined with BRAF and MEK inhibitors in BRAF V600E metastatic colorectal cancer by Eunyoung Tak, Hye-In An, Amy Sinyoung Lee, Kyuyoung Han, Jiwan Choi, Hyung-don Kim, Yong Sang Hong, Sun Young Kim, Eun Kyung Choi, Jeong Eun Kim, Tae Won Kim

    Published 2025-04-01
    Get full text
    Article
    Save to List
    Saved in:
  8. 8
    Blood TCTP as a potential biomarker associated with immunosuppressive features and poor clinical outcomes in metastatic gastric cancer

    Blood TCTP as a potential biomarker associated with immunosuppressive features and poor clinical outcomes in metastatic gastric cancer by Changhoon Yoo, Hyung-Don Kim, Min-Hee Ryu, Yeong Hak Bang, Jiae Kim, Won-Tae Kim, Hayoung Lee, Hideyuki Yanai, Gwanghee Lee, Hee Jeong Kim, Seyoung Jung, Hyung Eun Lee, Jaewon Hyung, Myeong-Jin Yoon, Jeong-Hyun Ryou, Hyungsu Jeon, Jeong Seok Lee

    Published 2025-03-01
    Get full text
    Article
    Save to List
    Saved in:
  9. 9
    Efficacy and safety of lenvatinib in patients with recurrent hepatocellular carcinoma after liver transplantation

    Efficacy and safety of lenvatinib in patients with recurrent hepatocellular carcinoma after liver transplantation by Kyunghye Bang, Andrea Casadei‐Gardini, Changhoon Yoo, Massimo Iavarone, Min‐Hee Ryu, Sook Ryun Park, Hyung‐Don Kim, Young‐In Yoon, Dong‐Hwan Jung, Gil‐Chun Park, Chul‐Soo Ahn, Deok‐Bog Moon, Shin Hwang, Ki‐Hun Kim, Gi‐Won Song, Chiara Mazzarelli, Eleonora Alimenti, Stephen L. Chan, Massimo De Giorgio, Baek‐Yeol Ryoo, Sung‐Gyu Lee

    Published 2023-02-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: